Bayer HealthCare / VEGF Trap-Eye (aflibercept ophthalmic injection) Recommended for Approval for the Treatment of Wet Age-Related Macular Degeneration in Europe

News Details

Please confirm that you are a medical journalist.
This website is intended to provide information to an international audience outside the USA and UK. Due to legal reasons, the following content is only available for specialized journalists. To access these pages, please confirm that you are a medical journalist and that you would like to accredit to the Bayer HealthCare press portal.

Bayer HealthCare Links

RSS Feed
RSS Feed

Copyright © Bayer HealthCare AG